Nature Medicine publica los datos del estudio de fase III de Stapokibart para la rinitis alérgica estacional ...Middle East

CHENGDU, China, 7 de abril de 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" o la "Compañía") anunció hoy que la prestigiosa revista médica Nature Medicine ha publicado los resultados del ensayo de fase III de su anticuerpo anti-IL-4Rα, stapokibart, desarrollado...

Hence then, the article about nature medicine publica los datos del estudio de fase iii de stapokibart para la rinitis alergica estacional was published today ( Monday 07/04/2025 - 10:57 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nature Medicine publica los datos del estudio de fase III de Stapokibart para la rinitis alérgica estacional )

Also on site :

• A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
• Enbridge aims to help North America win from the AI boom and the Iran war as the FedEx of energy delivery
• Quote of the Day: Organizational Psychologist Adam Grant on Rethinking Self-Doubt and Building Confidence